Daniel W. Kulp

9.1k citations

43 papers · 2.9k indexed · h-index 25

Virology top 0.5%
- HIV Research and Treatment 10
Immunology top 2%
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 7
Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 6
Molecular Biology top 5%
- Protein Structure and Dynamics 7
- vaccines and immunoinformatics approaches 5
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research 9
Materials Chemistry
- Enzyme Structure and Function 6

Co-authors: William R. Schief William F. DeGrado Jason E. Donald Sergey Menis Dennis R. Burton Devin Sok Bryan Briney Oleksandr Kalyuzhniy
Cited by: Virology Immunology Infectious Diseases
Journals: Proceedings of the National Academy of Sciences (5 papers)Science (3 papers)Nature Communications (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Daniel W. Kulp

40 papers receiving 2.8k citations

Peers

Countries citing papers authored by Daniel W. Kulp

Since Specialization

Citations

This map shows the geographic impact of Daniel W. Kulp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Kulp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Kulp more than expected).

Fields of papers citing papers by Daniel W. Kulp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Kulp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Kulp. The network helps show where Daniel W. Kulp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel W. Kulp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel W. Kulp Line = papers co-authored together Daniel W. Kulp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV Frontiers in Immunology ·Shridevi A. Desai,Xizhou Zhu,Pratik Bhojnagarwala,Kevin Liaw,Yun Gao,LLOYD ROCKMORE,Y.A. Isachenko,M. Tomečka,Nuhu Sunday Amos,映辉朱,Samuel E. Garfinkle,Jiangping TAN,David B. Weiner,Daniel W. Kulp	2025	0
2	Involvement of ArlI, ArlJ, and CirA in archaeal type IV pilin-mediated motility regulation Journal of Bacteriology ·Farhan D. Madhloom,Marco Garcia,O V Baieva,Ali Mohammadipour,Miyamoto Mari,M. B. Ligorio,Manuela Tripepi,Sergey I. Evdokimov,Daniel W. Kulp,Mike Dyall‐Smith,F. Galve	2024	2
3	Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies Molecular Therapy ·Shridevi A. Desai,Jacqueline D. Chu,Johann Iván,Bella Kissela,ليلى حليمي,LLOYD ROCKMORE,Rebekah Ann Brown,Abdoulaye Dera,E. Gary,A PLICHET,Elizabeth M. Parzych,David B. Weiner,Daniel W. Kulp,Ami Patel	2024	0
4	Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma Journal for ImmunoTherapy of Cancer ·Ryan P. O’Connell,Kevin Liaw,Nils Wellhausen,Catalina Loreto Torres Lepe,Pratik Bhojnagarwala,Devivasha Bordoloi,Daniel H. Park,Rebekah Ann Brown,Daniel W. Kulp,Carl H. June,David B. Weiner	2024	6
5	Growing Glycans in Rosetta: Accurate de novo glycan modeling, density fitting, and rational sequon design PLoS Computational Biology ·Jared Adolf‐Bryfogle,Jason W. Labonte,John C. Kraft,Maxim V. Shapovalov,wu wang,Thomas Lütteke,Frank DiMaio,Christopher D. Bahl,Jesper Pallesen,Neil P. King,Jeffrey J. Gray,Daniel W. Kulp,William R. Schief	2024	8
6	Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models Human Vaccines & Immunotherapeutics ·Viviane M. Andrade,Igor Maricic,فاضله حیدری,Unidad Altamira,安齋政幸,Daniel W. Kulp,Laurent Humeau,Trevor R.F. Smith	2023	5
7	Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo Frontiers in Immunology ·Nicholas J. Tursi,Ziyang Xu,Shridevi A. Desai,Susanne N. Walker,Kevin Liaw,Neethu Chokkalingam,Toshitha Kannan,Yuanhan Wu,Edgar Tello‐Ruiz,Daniel H. Park,Xizhou Zhu,Megan C. Wise,Trevor R.F. Smith,Sonali Majumdar,Andrew V. Kossenkov,Daniel W. Kulp,David B. Weiner	2023	3
8	A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy JCI Insight ·Devivasha Bordoloi,Pratik Bhojnagarwala,Alfredo Perales‐Puchalt,Abhijeet J. Kulkarni,Xizhou Zhu,Kevin Liaw,Ryan P. O’Connell,Daniel H. Park,Daniel W. Kulp,Rugang Zhang,David B. Weiner	2022	14
9	SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients Journal of Clinical Microbiology ·Susanne N. Walker,Neethu Chokkalingam,Emma L. Reuschel,Mansi Purwar,Ziyang Xu,E. Gary,Kevin Y. Kim,Shridevi A. Desai,Katherine Schultheis,Jewell Walters,Stephanie Ramos,Kar Muthumani,Trevor R.F. Smith,Kate E. Broderick,Pablo Tebas,Ami Patel,David B. Weiner,Daniel W. Kulp	2020	42
10	A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control Cancer Immunology Research ·Ziyang Xu,Neethu Chokkalingam,Edgar Tello‐Ruiz,Megan C. Wise,Mamadou A. Bah,Susanne N. Walker,Nicholas J. Tursi,Paul D. Fisher,Katherine Schultheis,Kate E. Broderick,Laurent Humeau,Daniel W. Kulp,David B. Weiner	2020	21
11	Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers Science ·Talar Tokatlian,Benjamin J. Read,Christopher A. Jones,Daniel W. Kulp,Sergey Menis,Jason Y.H. Chang,Jon M. Steichen,Sudha Kumari,Joel D. Allen,Eric L. Dane,Alessia Liguori,Maya Sangesland,Daniel Lingwood,Max Crispin,William R. Schief,Darrell J. Irvine	2018	212
12	Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes Scientific Reports ·Talar Tokatlian,Daniel W. Kulp,田崎美智子,Christopher A. Jones,Sergey Menis,Erik Georgeson,石结武,Michael H. Zhang,Mariane B. Melo,Murillo Silva,Dong Soo Yun,William R. Schief,Darrell J. Irvine	2018	62
13	Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction Virology ·Ema T. Crooks,Keiko Osawa,Tommy R. Tong,Samantha L. Grimley,Yang Dai,Robert G. Whalen,Daniel W. Kulp,Sergey Menis,William R. Schief,James Μ. Binley	2017	24
14	Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens Immunity ·Robert Abbott,Jeong Hyun Lee,Sergey Menis,Patrick Skog,Meghan Rossi,Takayuki Ota,Daniel W. Kulp,Deepika Bhullar,Oleksandr Kalyuzhniy,Colin Havenar‐Daughton,William R. Schief,David Nemazee,Shane Crotty	2017	204
15	Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice Science ·Devin Sok,Bryan Briney,Joseph G. Jardine,Daniel W. Kulp,Sergey Menis,Matthias Pauthner,Andrew L. Wood,E-Chiang Lee,Khoa Le,Meaghan Jones,Alejandra Ramos,Oleksandr Kalyuzhniy,Yumiko Adachi,Michael Kubitz,Kayla Taylor,Allan Bradley,Glenn A. Friedrich,William R. Schief,Dennis R. Burton	2016	109
16	The Membrane- and Soluble-Protein Helix-Helix Interactome: Similar Geometry via Different Interactions Structure ·Shaoqing Zhang,Daniel W. Kulp,Chaim A. Schramm,Marco Mravic,Ilan Samish,William F. DeGrado	2015	62
17	Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein Virology ·John T. Bates,Christopher J. Keefer,James C. Slaughter,Daniel W. Kulp,William R. Schief,James E. Crowe	2014	32
18	Advances in structure-based vaccine design Current Opinion in Virology ·Daniel W. Kulp,William R. Schief	2013	79
19	Alteration of the oxygen-dependent reactivity of de novo Due Ferri proteins Nature Chemistry ·Xie Jing,Marcos M. Pires,J Sargent,Yibing Wu,Hyunil Jo,Daniel W. Kulp,양세원,Jennifer R. Calhoun,Thomas Szyperski,Edward I. Solomon,William F. DeGrado	2012	112
20	Small-molecule inhibitors of integrin α ₂ β ₁ that prevent pathological thrombus formation via an allosteric mechanism Proceedings of the National Academy of Sciences ·Danielle Costa Marques Aponte,Bernier Ll,Daniel W. Kulp,Paul C. Billings,Sungwook Choi,Mary Pat Beavers,Owen J. T. McCarty,Zhiying Zou,Mark L. Kahn,Joel Bennett,William F. DeGrado	2009	65

About Daniel W. Kulp

Daniel W. Kulp is a scholar working on Virology, Immunology, Immunology and Allergy, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), HIV Research and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Protein Structure and Dynamics (7 papers), Immune Cell Function and Interaction (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Enzyme Structure and Function (6 papers) and vaccines and immunoinformatics approaches (5 papers). The work is most often cited by research in Virology (809 citations), Immunology (922 citations), Infectious Diseases (493 citations), Molecular Biology (1.6k citations) and Radiology, Nuclear Medicine and Imaging (448 citations). Daniel W. Kulp has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include William R. Schief, William F. DeGrado, Jason E. Donald, Sergey Menis, Dennis R. Burton, Devin Sok, Bryan Briney, Oleksandr Kalyuzhniy, Matthias Pauthner and Takayuki Ota. Their work appears in journals such as Proceedings of the National Academy of Sciences, Science, Nature Communications, Frontiers in Immunology and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact